Instrument Inactif

Autres langues Misonix, Inc.

Actions

MSON

US6048711039

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Misonix, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	26/04/22
Misonix, Inc.(NasdaqGM:MSON) dropped from S&P TMI Index	01/11/21
Misonix, Inc.(NasdaqGM:MSON) dropped from S&P Global BMI Index	01/11/21
MISONIX INC : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	29/10/21
Misonix, Inc.(NasdaqGM:MON) dropped from NASDAQ Composite Index	29/10/21
Bioventus Inc. completed the acquisition of Misonix, Inc. from Stavros G. Vizirgianakis, SV Life Sciences Fund VI, L.P. and Sv Life Sciences Fund VI Strategic Partners, L.P., funds managed by SV Health Investors, LLC, 1315 Capital, LLC and others.	29/10/21
MISONIX INC : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	26/10/21
MISONIX INC : Other Events (form 8-K)	18/10/21
MISONIX : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	02/09/21
Misonix : Q4 Net Loss Narrows, Revenue Surges	02/09/21
MISONIX : REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS (Form 8-K)	02/09/21
Misonix : Earnings Flash (MSON) MISONIX Posts Q4 Revenue $19.7M	02/09/21
Misonix : Reports Fourth Quarter and Fiscal Year 2021 Financial Results	02/09/21
Misonix, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	02/09/21
MISONIX INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	12/08/21
Misonix, Inc. Announces Nonrenewal of Allan Staley as President and Named Executive Officer	12/08/21
MISONIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Misonix, Inc. - MSON	31/07/21
Misonix : Bioventus to Acquire Misonix in Cash-and-Stock Deal Valued at $518 Million	30/07/21
NASDAQ 100 : Top Midday Gainers	30/07/21
Misonix : FORM OF VOTING AND SUPPORT AGREEMENT (Form 8-K)	29/07/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Misonix, Inc.

Actions

MSON

US6048711039

Autres langues

Filtres